403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Patient Safety At Risk: Former FDA Official Warns Of Dangers From Compounded GLP-1S
(MENAFN- EIN Presswire) EINPresswire/ -- As the demand for GLP-1 medications skyrockets, patients are increasingly targeted with compounded knockoffs that are not FDA approved and do not meet federal safety or quality standards. Many are mass-produced using unverified foreign ingredients and marketed deceptively as“personalized” care.
Research shows patients using these products are twice as likely to be hospitalized compared with those on FDA-approved treatments-underscoring urgent risks for millions of Americans seeking weight-loss or diabetes care. Leigh Verbois, PharmD, JD, FAPhA – Current board member of the Alliance for Safe Online Pharmacies (ASOP Global) and former FDA official, shares more about this concerning topic.
For more information, please visit .
Research shows patients using these products are twice as likely to be hospitalized compared with those on FDA-approved treatments-underscoring urgent risks for millions of Americans seeking weight-loss or diabetes care. Leigh Verbois, PharmD, JD, FAPhA – Current board member of the Alliance for Safe Online Pharmacies (ASOP Global) and former FDA official, shares more about this concerning topic.
For more information, please visit .
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment